Immediate protein targets of photodynamic treatment in carcinoma cells

Pavel A Tsaytler1, Martina C O'Flaherty, Dmitri V Sakharov

  • 1Department of Membrane Enzymology, Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands.

Insights

Photodynamic treatment (PDT) causes oxidative stress in tumor cells, modifying 314 proteins. This study identifies key protein targets, aiding understanding of cancer treatment mechanisms.

Area of Science:

  • Biochemistry
  • Oncology
  • Proteomics

Background:

  • Photodynamic treatment (PDT) induces oxidative stress in tumor cells.
  • Protein oxidation, particularly carbonyl and thiol modifications, is a key cellular response.

Purpose of the Study:

  • To identify immediate protein targets of PDT-induced oxidative stress in A431 tumor cells.
  • To elucidate mechanisms of PDT-induced apoptosis via protein modification analysis.

Main Methods:

  • Proteomic approach utilizing selective biotinylation.
  • Affinity purification and mass spectrometric identification of modified proteins.

Main Results:

  • 314 proteins were identified as undergoing PDT-mediated oxidative modifications.
  • Carbonylated proteins included structural proteins and chaperones.
  • Oxidized thiol labeling identified low-abundance proteins involved in signaling and redox homeostasis.

Conclusions:

  • Protein oxidation is a significant cellular response to PDT.
  • Identification of specific protein targets provides insights into PDT-induced apoptosis.
  • Findings may enhance targeted photodynamic cancer therapy.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...